Trial intelligence / Profile preview

PROCRIT for Anemia in Lymphoma, CLL, and MM

NCT00524407Phase 4Completed

Sponsor
Ortho Biotech Inc.
Start
Jul 1996
Modality
Biologic, rProtein (Recombinant Protein)
01

Overview

A Phase 4 trial of epoetin alfa in anemia, sponsored by Ortho Biotech Inc.. Started Jul 1996; status: completed.

02

Drugs

epoetin alfa
03

Conditions

anemia

Beyond the preview

Go deeper on NCT00524407.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00524407.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call